The global Pancreatic Cancer Therapeutics and Diagnostic Market is estimated to be valued at US$ 3,689.6 Mn in 2022 and is expected to exhibit a CAGR of 7.4% over the forecast period 2023-2028, as highlighted in a new report published by Coherent Market Insights.Market Overview:Pancreatic cancer is one of the deadliest forms of cancer, with a low survival rate. The market for pancreatic cancer...